Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director CC transcript
|
Steel Excel Inc. (ADPT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/10/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/10/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/02/2023 |
4
| STEEL PARTNERS HOLDINGS L.P. (10% Owner) has filed a Form 4 on Steel Connect, Inc.
Txns:
| Granted 112,043 options to buy
@ $1.1, valued at
$123.2k
Granted 3,387,957 options to buy
@ $1.1, valued at
$3.7M
|
|
02/13/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
11/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/11/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
11/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
08/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
05/14/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
04/27/2021 |
GN
| Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference |
03/17/2021 |
GN
| Adaptive Biotechnologies Strengthens Expertise and Diversity of Board of Directors with Appointments of Leslie Trigg and Katey Owen |
03/05/2021 |
GN
| Adaptive Biotechnologies Announces FDA Emergency Use Authorization for T-Detect™ COVID to Confirm Recent or Prior COVID-19 Infection |
02/25/2021 |
GN
| Adaptive Biotechnologies to Present at the Cowen 41st Annual Healthcare Conference |
02/23/2021 |
GN
| Adaptive Biotechnologies Expands Collaboration with Labcorp to Increase Access to Growing Research and Clinical Diagnostic Portfolio |
02/23/2021 |
GN
| Adaptive Biotechnologies Launches T-Detect™ COVID, First Clinical T-Cell Based Test for Patients to Confirm Recent or Prior COVID-19 Infection |
02/12/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
02/03/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/28/2021 |
SC 13D/A
| Steel Excel Inc. reports a 7.8% stake in Aviat Networks, Inc. |
01/27/2021 |
4
| Steel Excel Inc. (10% Owner) has filed a Form 4 on AVIAT NETWORKS, INC.
Txns:
| Sold 31,787 shares
@ $37.8513, valued at
$1.2M
|
|
01/11/2021 |
GN
| Adaptive Biotechnologies to Collaborate with AstraZeneca in Mapping the Immune Response to Cancer Antigens to Potentially Inform the Development of Novel Diagnostics and Therapeutics |
12/30/2020 |
GN
| Adaptive Biotechnologies to Present at the 39th Annual J.P. Morgan Healthcare Conference |
12/22/2020 |
SC 13D/A
| Steel Excel Inc. reports a 10.1% stake in Aviat Networks, Inc. |
12/21/2020 |
4
| Steel Excel Inc. (10% Owner) has filed a Form 4 on AVIAT NETWORKS, INC.
Txns:
| Sold 464 shares
@ $37.9491, valued at
$17.6k
Sold 5,400 shares
@ $37.0002, valued at
$199.8k
|
|
12/17/2020 |
4
| Steel Excel Inc. (10% Owner) has filed a Form 4 on AVIAT NETWORKS, INC.
Txns:
| Sold 35,100 shares
@ $37.3059, valued at
$1.3M
|
|
12/17/2020 |
SC 13D/A
| Steel Excel Inc. reports a 10.2% stake in Aviat Networks, Inc. |
12/16/2020 |
4
| Steel Excel Inc. (10% Owner) has filed a Form 4 on AVIAT NETWORKS, INC.
Txns:
| Sold 27,159 shares
@ $37.5305, valued at
$1M
Sold 24,128 shares
@ $37.5086, valued at
$905k
|
|
12/14/2020 |
SC 13D/A
| Steel Excel Inc. reports a 11.3% stake in Aviat Networks, Inc. |
12/11/2020 |
4
| Steel Excel Inc. (10% Owner) has filed a Form 4 on AVIAT NETWORKS, INC.
Txns:
| Sold 10,244 shares
@ $40.5022, valued at
$414.9k
Sold 14,000 shares
@ $38.0075, valued at
$532.1k
|
|
12/06/2020 |
GN
| Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting |
11/23/2020 |
GN
| Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients |
|
|
|